Moreover, about one-third of depressed patients showed a low-grade inflammatory state (i.e., CRP > 3.0 mg/L), by suggesting the presence of a different MDD subgroup with a distinct etiopathogenesis, clinical course, treatment response, and prognosis which may benefit of a monitoring of CRP levels and might potentially respond to anti-inflammatory treatments. This evidence concerns the gene CRP and major depressive disorder.